ICU vs PRLD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

ICU

42.9
AI Score
VS
ICU Wins

PRLD

36.2
AI Score

Investment Advisor Scores

ICU

43score
Recommendation
HOLD

PRLD

36score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric ICU PRLD Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 82.0% 41.0% ICU
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 42.9/100 36.2/100 ICU
Profit Margin 0.0% -269.8% ICU
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

ICU 1M: -14.4% · 3M: -14.4% PRLD 1M: +72.2% · 3M: +54.4%

Current Technical Phase

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.3%), weak momentum, RSI 42

RSI (14): 42.2 · Price: $3.21

PRLD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.3% over 20 days), RSI 74

RSI (14): 74.2 · Price: $6.60

Fundamentals Snapshot

Metric ICU PRLD
Market Cap
Forward P/E -1.4 -8.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.8% 0.4%
Gross Margin 0.9% 1.0%
Operating Margin -6.2% -2.7%
EPS -1.89 -0.73
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ICU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.